Key result
First ASCVD event linked to ~42% five-year risk of recurrence or death.
Why the study?
Many patients live with atherosclerotic CV disease and remain at risk of life-threatening events, prompting evaluation of the risk for recurrent CV events or death in real-world data.
Cohort (n=48,405)
Yes
Following a first atherosclerotic cardiovascular event, patients face a high risk of recurrence or death, particularly within the first 6 months, highlighting the critical need for prompt secondary prevention measures.
High recurrent risk after first ASCVD event suggests need for intensified secondary prevention; leaves open optimal strategies in prospective trials.
BACKGROUND: A large number of patients are living with atherosclerotic cardiovascular (CV) disease and thus are at risk of life-threatening CV events. HYPOTHESIS: This study evaluated the risk for a recurrent CV event or death in Finnish real-world data. METHODS: Patients with an incident atherosclerotic CV event between 2012 and 2016 were included in this retrospective registry study and followed for recurrent CV events or death. The risk and risk factors of recurrent CV events or death and time from the first CV event to recurrence were assessed. RESULTS: A total of 48,405 patients were followed from their first CV event. The event rate was 14.34 events per 100 patient-years. Multistate models suggested that at 5 years post index CV event, 41.5% of the patients had died or suffered a recurrent CV event. Death was the most common type of subsequent event (61.5%). After the first CV event, there were rapid increases both in recurrent CV events and deaths during the next 6 months. The subsequent CV event was usually of the same type as the first, which was of the cardiac or cerebrovascular cluster. CONCLUSIONS: The incidence of recurrent CV events and all-cause mortality was high in patients suffering from their first CV event, particularly during the first 6 months after the index event. Death was the most common subsequent event. The event rate accelerated after each additional CV event. This suggests that the acute treatment of the index event should be followed by prompt secondary prevention measures to achieve guideline-recommended goals as soon as possible.
No takes yet. Share an insight, caveat, or question.
Toppila et al. (2022) conducted a cohort in Atherosclerotic cardiovascular disease (n=48,405). In patients with a first atherosclerotic cardiovascular event, the combined rate of recurrent events and all-cause mortality was 14.34 per 100 patient-years, reaching 41.5% at 5 years.
Synapse has enriched 5 related papers. Consider them for comparative context: